Tekla Capital Management LLC Lexicon Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$4.36 - $7.94 $305,200 - $555,800	-70,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$10.32 - $13.06 $722,400 - $914,200	70,000 New	70,000 $747,000
Q2 2018 Aug 13, 2018	SELL	$7.8 - $13.69 $1.8 Million - $3.16 Million	-231,054 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$7.86 - $11.39 $374,497 - $542,687	-47,646 Reduced 17.1%	231,054 $1.98 Million
Q4 2017 Feb 14, 2018	BUY	$8.77 - $12.28 $2.44 Million - $3.42 Million	278,700	278,700 $2.75 Million

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $185M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.